JP2010512393A5 - - Google Patents

Download PDF

Info

Publication number
JP2010512393A5
JP2010512393A5 JP2009541336A JP2009541336A JP2010512393A5 JP 2010512393 A5 JP2010512393 A5 JP 2010512393A5 JP 2009541336 A JP2009541336 A JP 2009541336A JP 2009541336 A JP2009541336 A JP 2009541336A JP 2010512393 A5 JP2010512393 A5 JP 2010512393A5
Authority
JP
Japan
Prior art keywords
solution
free
substantially cell
cells
assembling peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009541336A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512393A (ja
JP5558104B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/025271 external-priority patent/WO2008073395A2/en
Publication of JP2010512393A publication Critical patent/JP2010512393A/ja
Publication of JP2010512393A5 publication Critical patent/JP2010512393A5/ja
Application granted granted Critical
Publication of JP5558104B2 publication Critical patent/JP5558104B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009541336A 2006-12-11 2007-12-11 心組織の保護および再生のための組成物および方法 Expired - Fee Related JP5558104B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86943706P 2006-12-11 2006-12-11
US60/869,437 2006-12-11
PCT/US2007/025271 WO2008073395A2 (en) 2006-12-11 2007-12-11 Compositions and methods for cardiac tissue protection and regeneration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013097308A Division JP5903068B2 (ja) 2006-12-11 2013-05-07 心組織の保護および再生のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2010512393A JP2010512393A (ja) 2010-04-22
JP2010512393A5 true JP2010512393A5 (https=) 2012-01-12
JP5558104B2 JP5558104B2 (ja) 2014-07-23

Family

ID=39183217

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009541336A Expired - Fee Related JP5558104B2 (ja) 2006-12-11 2007-12-11 心組織の保護および再生のための組成物および方法
JP2013097308A Expired - Fee Related JP5903068B2 (ja) 2006-12-11 2013-05-07 心組織の保護および再生のための組成物および方法
JP2015228381A Withdrawn JP2016033147A (ja) 2006-12-11 2015-11-24 心組織の保護および再生のための組成物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013097308A Expired - Fee Related JP5903068B2 (ja) 2006-12-11 2013-05-07 心組織の保護および再生のための組成物および方法
JP2015228381A Withdrawn JP2016033147A (ja) 2006-12-11 2015-11-24 心組織の保護および再生のための組成物および方法

Country Status (6)

Country Link
US (2) US9012404B2 (https=)
EP (1) EP2089047B1 (https=)
JP (3) JP5558104B2 (https=)
DK (1) DK2089047T3 (https=)
ES (1) ES2400294T3 (https=)
WO (2) WO2008073392A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5255274B2 (ja) * 2004-07-06 2013-08-07 スリーディー マトリックス, インコーポレイテッド 精製両親媒性ペプチド組成物およびその使用
JP5497451B2 (ja) * 2007-12-05 2014-05-21 株式会社スリー・ディー・マトリックス 創傷治癒・皮膚再建材
RU2011118341A (ru) * 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
AP2011005824A0 (en) * 2009-01-26 2011-08-31 Intermune Inc Methods for treating acute myocardial infarctions and associated disorders.
US20110117195A1 (en) * 2009-11-18 2011-05-19 National Cheng Kung University Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers
JP6034868B2 (ja) * 2011-09-02 2016-11-30 株式会社スリー・ディー・マトリックス 胸部の空気漏れ閉塞のための両親媒性ペプチド
US10905708B2 (en) 2011-09-07 2021-02-02 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
US11260072B2 (en) 2011-09-07 2022-03-01 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
JP2015021582A (ja) 2013-07-22 2015-02-02 株式会社ジェイテクト 円錐ころ軸受と円錐ころ軸受を用いた動力伝達装置
BR112016019510A2 (pt) 2014-03-10 2017-10-24 3 D Matrix Ltd esterilização e filtração de composições de peptídeos
RU2016139369A (ru) 2014-03-10 2018-04-10 3-Д Матрикс, Лтд. Композиции самоорганизующихся пептидов
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
DE102015000363A1 (de) 2015-01-20 2016-07-21 Emc Microcollections Gmbh Neue modular funktionalisierbare Peptid-Hydrogele
US10702606B2 (en) 2015-12-10 2020-07-07 Menicon Co., Ltd. Peptide composition
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
JP2021506815A (ja) 2017-12-15 2021-02-22 株式会社スリー・ディー・マトリックス 界面活性ペプチドナノ構造および薬物送達における使用
EP3818071A2 (en) * 2018-07-03 2021-05-12 3-D Matrix, Ltd. Ionic self-assembling peptides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
AU7178301A (en) * 2000-07-06 2002-01-21 American Home Prod Methods for increasing nitric oxide synthase activity
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
AU2003249606A1 (en) 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
PL376213A1 (en) * 2003-01-16 2005-12-27 Boehringer Ingelheim International Gmbh Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
EP2711025A3 (en) * 2003-06-25 2014-09-10 Massachusetts Institute of Technology Self-assembling peptides incorporating modifications and methods of use thereof
US7713923B2 (en) * 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
JP4813771B2 (ja) * 2004-04-14 2011-11-09 丸善製薬株式会社 血管内皮型一酸化窒素合成酵素活性促進剤
JP5255274B2 (ja) 2004-07-06 2013-08-07 スリーディー マトリックス, インコーポレイテッド 精製両親媒性ペプチド組成物およびその使用
JP4949661B2 (ja) * 2004-09-21 2012-06-13 第一三共株式会社 HMG−CoAリダクターゼ阻害剤とグルタチオンを含有する医薬組成物
JP2008526749A (ja) * 2005-01-04 2008-07-24 ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド 自己アセンブリするペプチドナノファイバーを用いたpdgfの徐放性の送達
DK1879606T3 (da) * 2005-04-25 2013-09-23 Massachusetts Inst Technology Selvorganiserende peptider til fremme af hæmostase

Similar Documents

Publication Publication Date Title
JP2010512393A5 (https=)
Haylor et al. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I
JP7175506B2 (ja) 低血圧治療のための単独または併用使用されるアンギオテンシンii
WO2008073392A3 (en) Compositions and methods for cardiac tissue protection and regeneration
US11414474B2 (en) Long-acting adrenomedullin derivatives
JP2023511358A5 (https=)
AU2005251386B2 (en) Compositions and methods for treatment of cardiovascular disease
CA2422078C (en) High efficiency cardiac gene transfer
CA2740989A1 (en) Compositions and methods for treatment of kidney fibrosis comprising vasoactive intestinal peptide (vip) or functional vip fragments
WO2017152039A1 (en) Protection and delivery of multiple therapeutic proteins
KR20210093958A (ko) 미토콘드리아 질환을 표적으로 하는 유사체
EP1031352B1 (en) Use of desmopressin in the preparation of a metastatic dissemination inhibitor medicament during cancer surgery
US20250276116A1 (en) Methods of mitigating myocardial damage due to extracorporeal membrane oxygenation
WO2012138043A2 (en) Therapeutic composition containing endothelin as an active component
Hatori et al. Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion
WO2016168694A1 (en) Engineered calmodulin for treatment of ryanopathies
HK40050536A (en) Angiotensin ii alone or in combination for the treatment of hypotension
CN120399139A (zh) 聚合物psnp及合成方法、基于该聚合物的水凝胶及其应用
HK40039808A (en) Angiotensin ii alone or in combination for the treatment of hypotension
CN107050435B (zh) 一种钠尿肽极化液及其制备方法和应用
CN103006632B (zh) 化合物Clik148在制备治疗脑血管疾病的药物中的应用
has been proposed that EDs Letters to the
Hatada et al. Direct delivery of neuronal nitric oxide synthase into myocardium improves heart failure after acute myocardial infarction in rats
Kamiya et al. Beta-3 adrenergic receptor agonist prevents diastolic dysfunction in angiotensin2-induced cardiomyopathy mouse model
Gol’dberg et al. Effect of granulocyte colony-stimulating factor on myocardium recovery in postinfarction period